Navigation Links
New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia

formation, such as slit lamp exam or other appropriately sensitive methods, is recommended at initiation of treatment or shortly thereafter, and at 6-month intervals during chronic treatment.

The most commonly observed adverse events associated with the use of SEROQUEL monotherapy versus placebo in clinical trials for schizophrenia and bipolar disorder were dry mouth (9-44% vs 3-13%), sedation (30% vs 8%), somnolence (18-28% vs 7-8%), dizziness (11-18% vs 5-7%), constipation (8-10% vs 3-4%), SGPT increase (5% vs 1%), dyspepsia (5-7% vs 1-4%), lethargy (5% vs 2%), and weight gain (5% vs 1%). The most commonly observed adverse events associated with the use of SEROQUEL versus placebo in clinical trials as adjunct therapy with lithium or divalproex in bipolar mania were somnolence (34% vs 9%), dry mouth (19% vs 3%), asthenia (10% vs 4%), constipation (10% vs 5%), abdominal pain (7% vs 3%), postural hypotension (7% vs 2%), pharyngitis (6% vs 3%), and weight gain (6% vs 3%).

Please see the full Prescribing Information including Boxed Warnings for SEROQUEL available at http://www.seroquel.com .

About Schizophrenia

Schizophrenia is a serious brain disorder with symptoms including distorted perceptions of reality, hallucinations and delusions, illogical thinking, and flat or blunted emotions.(4) Schizophrenia affects men and women with equal frequency, but the first signs of schizophrenia typically emerge earlier in men (in late teens or early twenties) compared to women (in twenties or early thirties).(5) Over 2 million American adults -- about 1 percent of the population age 18 and older -- suffer from schizophrenia. Medications are important in the management of symptoms. While there is no cure for schizophrenia, it is a highly treatable and manageable illness. Medications are classified into two categories -- "conventional" and "atypical" antipsychotics.(6)

About AstraZeneca


'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
(Date:3/26/2015)... and VANCOUVER, British Columbia, March 26, 2015 /PRNewswire/ ... provided a summary of clinical developments and announced ... Clinical Developments and Anticipated Near-term ... OncoGenex and Teva agreed to negotiate the termination ... OncoGenex. Negotiations of the final termination agreement are ...
(Date:3/26/2015)... S.C. , March 26, 2015 ... told by their existing PACS vendor their system ... (CMH) determined that they needed a better structured ... Hospital selected Avreo interWORKS due to its interface ... modern meaningful use standards through to the hospital,s ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2
(Date:3/27/2015)... The Thomas Scattergood Behavioral ... foundation committed to raising its voice to improve ... , The Scattergood Foundation and The Kennedy Forum ... and Practice through the Annual Scattergood Foundation Innovation ... is designed to guide the IBS sufferer through ...
(Date:3/26/2015)... 26, 2015 Elfster.com, the top-rated Secret ... its bucket list generator capabilities to its leading Secret ... to a list that one creates of things to ... movie of the same name. Nowadays many millennials ... memorialize their summer achievements. , "We are greatly expanding ...
(Date:3/26/2015)... TX (PRWEB) March 26, 2015 ... the 32nd annual Dallas Rhinoplasty Symposium and has ... years, reiterated the importance of evidence based medicine (EBM), ... evidence from well conducted research. , "We often hear ... to rhinoplasty, and while we are certainly not trying ...
(Date:3/26/2015)... Franklin, TN (PRWEB) March 26, 2015 ... http://www.healthclick.com . This website is dedicated to providing information ... therapy and occupation therapy community. As a leader ... North American Seminars provided over 200 live and online ... PT OT continuing Education Courses :, A Master Clinicians ...
(Date:3/26/2015)... Francisco, CA (PRWEB) March 26, 2015 The ... These will be on the topics of the DAOM Program ... The DAOM Program Overview Webinar will be hosted by Dr. ... and provide the next steps on how to prepare for ... 12:30 p.m. March 25, March 27, April 1 and April ...
Breaking Medicine News(10 mins):Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:ACTCM Announces Upcoming Webinars 2
... community outreach program in Delaware has thought of an ... ,Its “Do the Right Thing 4Life” program—supported by AIDS ... well as condoms, to people via the participating barbershops ... by Frank Hawkins, director of education and community outreach ...
... low fat diet into old age, according to a new ... study on nearly 50,000 post-menopausal women in the US, //published ... Association (JAMA), comes to the conclusion that reducing fat intake ... to maintain a stable weight. , ,This discredits ...
... weed, which contains a chemical called cannabinoids which contains a ... “high” effect on the brain. // Due to its high ... be cultivated as an indoor plant under the lamps without ... than 20 times of THC than the one cultivated 30 ...
... WinRho drug, used for treating bleeding disorders. According to Baxter ... to trigger fatal side effects, albeit rarely.// ... States since 1995, and is used to treat a bleeding ... with requisite number of platelets, to form clots. Winrho-related complications ...
... It has been known for long now that Vitamin D ... that Vitamin D supplementation in pregnant// women could lead to ... to a study it has been shown that children whose ... to have weaker bones. ,It is a common ...
... NHS could suffer a big blow if the financial condition ... the Audit Commission.// The prevalence of a weak financial management, ... by district auditors have been accounted for the present condition. ... trusts and hospitals is believed to reach ?75m by the ...
Cached Medicine News:Health News:NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey 2
... determination of Estradiol (E2) concentration in human serum ... hormone with a phenolic A ring. This ... It is the most potent natural Estrogen, ... smaller amounts by the adrenal cortex, and the ...
... potent, naturally secreted estrogen and is the ... In the ovary, estradiol is produced from ... potent estrogen derived from androstenedione. Estrone and ... In men, small amounts of estradiol are ...
... VITROS ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The VITROS ECi can simultaneously process ...
Clinical marker immunoassay kit for detection of Myoglobin....
Medicine Products: